Contact Us
Our Location

Health Sciences Centre, University of Calgary, Calgary, Alberta

Telephone Number

(403) 210-7570

Email Address

national.manager@copn-rpco.ca

Projects

Research Projects Utilizing Canadian Open Parkinson Network (C-OPN) Data

The Canadian Open Parkinson Network (C-OPN) provides an invaluable resource for advancing Parkinson’s disease research. Below are some innovative projects that have leveraged C-OPN’s comprehensive dataset.

Request NumberRequest TypeResearcher Name (Requester)Principal Investigator (if applicable)Institution/OrganizationProject Title
1DataHelena DenisDr. Francesca CicchettiCHUQLes vésicules extracellulaires dérivées d'érythrocyte: biomarqueurs de la maladie de Parkinson
2DataDr. Juan LiDr. Michael SchlossmacherOttawa Hospital Research Institute (OHRI)/ University of OttawaValidation of the PREDIGT Score for the Incidence of Parkinson's Disease compared to Healthy Subjects
3DataDr. Iris KatholDr. Oury MonchiUniversity of CalgaryPD-MBI-GEN
4DataIbukun OjoDr. Fang Ba and Dr. MyasakiUniversity of AlbertaEthnic and Gender Disparities in Access to Deep Brain Stimulation Surgery
5DataDr. James McVittieDr. James McVittieUniversity of ReginaImprove survival analysis methodologies for combining different types of cohort data and modelling measurement error in reported dates of onset of disease
6Data and MaterialGP2 TeamDr. Andrew SingletonNIHC-OPN & Global Parkinson’s Genetics Program (GP2)
7Data and MaterialDr. Aarnoud van der SpoelDr. Aarnoud van der SpoelDalhousie UniversityImprove survival analysis methodologies for combining different types of cohort data and modelling measurement error in re+[@[Project Title]]ported dates of onset of disease
8Data and MaterialMeron TeferraDr. Ziv Gan-OrMcGill UniversityThe genetics of REM sleep behavior disorder, Parkinson’s disease and other synucleinopathies
9Data and MaterialCatherine DeryDr. Nicolas Dupré and Dr. Manon BouchardCHU de Québec - Université Laval Research CentreAssociation between levodopa-carbidopa dose, plasma vitamin B6 deficiency and polyneuropathy in patients with a parkinsonian syndrome: data from the Canadian Open Parkinson Network
10DataDr. Aurélie de Rus Jacquet; C-OPN TeamDr. Francesca CicchettiCHUQClinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experience
11RegistryZi Hui (Lily) Su Zi SuDr. Chrystalina AntoniadesOxford UniversityOnline population study on time perception in Parkinson's disease and aged population
12RegistryPénélope BernierDr. Pierre-Yves TherriaultUniversité du Québec à Trois-RivièresL’utilisation de la domotique en ergothérapie : perception d’utilisateurs atteints de la maladie de Parkinson
13RegistryPetra UzelmanDr. Silke CresswellUniversity of British ColumbiaTreating anxiety in Parkinson’s disease with a multi-strain probiotic – a randomized, placebo-controlled trial
14RegistryDr. Madeleine SharpDr. Madeleine SharpMcGill UniveristyDeep cognitive endophenotyping of Parkinson’s disease: A platform development and pilot study.
15RegistryDr. Ryan D'ArcyDr. Ryan D'ArcyUniversity of British ColumbiaMultimodal neuromodulation in individuals with Parkinson's Disease
16RegistryDr. Tejas SankarDr. Tejas SankarUniversity of AlbertaChanges in spinal reflexes used post-operatively as a biomarker for optimized treatment from deep brain stimulation in Parkinson's disease
17RegistryDr. Richard Camicioli and Dr. Kelvin JonesDr. Richard Camicioli and Dr. Kelvin JonesUniversity of AlbertaStudy in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
18RegistryDr. Ayse KuspinarDr. Ayse KuspinarMcMaster UniversityDevelopment of a new health-related quality of life measure for Parkinson’s disease
19RegistryDr. Penny MacDonaldDr. Penny MacDonaldUniversity of WesternEstablishing definitive MRI diagnostic testing of Parkinson's disease
20RegistryDr. Martin McKeownDr. Martin McKeownUniversity of British ColumbiaDevelopment of a new health-related quality of life measure for Parkinson’s disease
21RegistryDr. Kathryn LambertDr. Ada LeungUniversity of AlbertaExamining the contribution of executive functions to motor imagery ability in people with Parkinson's disease and healthy older adults
22DataDr. Lorraine KaliaDr Kalia LorraineToronto Western Hospital: University Health Network (UHN)Cultural Considerations in Daily Levodopa Equivalent Dosage: A Study of Global Population
23Data and Material PhD Nikhil Parag Bhagwat PhD Nikhil Parag BhagwatMcGill UniversityQuebec Parkinson Network cohort: A standardized and preprocessed neuroimaging and clinical dataset for PD biomarker discovery
24DataDr Aurélie de Rus JacquetDr Aurélie de Rus JacquetCentre de recherche du CHU de Québec-Université LavalParkinson's Disease in Quebec: Mapping Project
25Data and MaterialMathieu BlaisDr Nicolas DupréCHU de Québec – Université LavalÉtude épidémiologique et génétique de la maladie de Parkinson au Québec
26DataGabriel David PinillaDr Oury MonchiCentre de recherche de l'IUGM
Université de Montréal (Quebec)
C-OPN Cohort Genetic Profile
27DataCristiane Ribeiro ChavesCristiane Ribeiro ChavesLaboratoire de recherche en audition et vieillissement - CRIUGMMaladie de Parkinson et ses répercussions sur la voix, la participation sociale et la qualité de vie
28DataAlavash MohshenProf. Dr. med. Thomas MünteUniversity of LübeckStudying brain resting-state neural dynamics in Parkinson disease using MEG and their relation to clinical outcomes
29DataNicolas FerryDr Aurélie de Rus JacquetCentre de recherche du CHU de Québec-Université LavalC-OPN PBMC analysis
30Data and MaterialAymeric LanoreDr Jean-Christophe CorvolParis Brain InstitutePRECISE-PD & C-OPN Collaboration
31DataGail DimapilisDr Fang BaUniversity of AlbertaEthnic and Gender Disparities in Access to Deep Brain Stimulation Surgery for Movement Disorders.
32DataDr Aurélie de Rus JacquetDr Aurélie de Rus JacquetCentre de recherche du CHU de Québec-Université LavalReprogramming C-OPN's Indigenous PBMCs into iPSCs
33DataDr. Catalina Cerquera ClevesDr. Catalina Cerquera ClevesCHU de Québec – Université Laval2nd cohort Manuscript
34RegistryDr. Judith BekDr. Judith BekUniversity of TorontoDancing with the mind and body: Exploring strategies for movement through dance in Parkinson’s 
35RegistryCaitlin KelliherMJFFMJ Fox FoundationParkinson's Progression Markers Initiative (PPMI)
36RegistryDr. Madeleine SharpDr. Madeleine SharpMcGill UniveristyPatient Attitudes about Clinical Trial Participation 
37RegistryYuko KoshimoriDr. Michael ThautUniversity of TorontoDoes motor synchronization to Rhythmic Auditory Stimulation (RAS) alter dopamine responses in Parkinson’s disease? 
38RegistryWaad AlOlayanDr. Jana RiegerUniversity of AlbertaTechnology for Swallowing Exercises in Parkinson's Disease: A Usability Study
39DataHailu, Ambachew Dena Hernandez NIHNIH Genotyping Experiment
40MaterialZaid Al AzzawiDr. Ted FonMcGill UniversityBiochemical and pathological characterization of synuclein aggregates from PD and RBD patient plasma
41DataDr. Alain DagherDr. Alain DagherMcGill University Ethnicity data contributed to NIH grant application
42MaterialShawna ReddieDr. David GrimesOttawa Hospital Research InstituteStudy on Parkinson's disease in patients with GBA mutation
43DataDr. Silke CresswellDr. Silke CresswellUniversity of British ColumbiaInformation on Early PD among C-OPN cohort
44DataDr. James McVittieDr. James McVittieUniversity of ReginaDeveloping a procedure to estimate the unknown parameters in a proportional hazards model using current lifetime data
45Data and MaterialDr. Davide MartinoDr. Davide MartinoUniversity of CalgaryC-OPN CAPRI LRRK2 mutations participant list
46Data and MaterialMadeleine PowellDr. Jon StoesslUniversity of British ColumbiaC-OPN UBC GBA mutations participant list
47DataLietsel JonesGP2 InitiativeGP2Updated of C-OPN GP2 Clinical Data
48DataLe XingDr. Zhiying LongBeijing Normal UniversityStudy on Brain Dynamics in Parkinson's Disease Using MEG Data
49DataMathieu BlaisDr. Catalina Cerquera ClevesCHUQ - ULavalExploring the relationship between diabetes and symptom severity in PD
50DataHamzeh Norouzi (PhD)Hamzeh Norouzi (PhD)University of StirlingValidating article by QPN: "Structural and neurophysiological alterations in Parkinson’s disease are aligned with cortical neurochemical systems
51DataAndrew VoDr. Nikhil Parag BhagwatMcGill UniversityUpdate on Quebec Parkinson Network cohort: A standardized and preprocessed neuroimaging and clinical dataset for PD biomarker discovery
52DataMuhammad FaranMuhammad FaranVancouver Fraser Medical ProgramCohort study of individuals not receiving DBS vs receiving DBS on non motor symptoms.
53RegistryPamela Harrison and Caitlin KelliherMJFFMJ Fox FoundationParkinson's Progression Markers Initiative (PPMI) - Phase II
54RegistryNeil BoytDr. Aileen HoUniversity of Reading, UKBrief Exercise in Guided and Reflective Writing for PD Study
55RegistryNisha PulimoodDr. Ron PostumaMcGill UniveristyA multi-site longitudinal cohort study of Prodromal and Clinical PD
56RegistryStéphanie LavigneDr. Michal ThautUniversity of TorontoFunctional Brain Networks of Auditory-Motor Synchronization in Healthy adults and in adults with PD

These projects exemplify the diverse and impactful research enabled by the C-OPN, driving forward our understanding and treatment of Parkinson’s disease.



Note that this list was last updated November 2024.